Because a single vial covers several weekly doses, a repeated one- or two-unit error compounds across the whole vials life
LSN3160440: a , L142A, b , Y145A, c , K202A, and d , L142A, Y145A, K202A
It received an FDA warning letter in September 2025 for misleading compounded semaglutide marketing claims, launched a compounded semaglutide pill in February 2026 that was referred to the DOJ within days and pulled within 48 hours, was sued by Novo Nordisk for patent infringement, and then reached a deal with Novo Nordisk in March 2026 to offer branded Ozempic directly through the platform
Recommended Dosage: The appropriate dosage may vary depending on your individual needs and health conditions
History of Pancreatitis: Although its not completely understood why pancreatitis occurs from semaglutide, it can cause this side effect, particularly in those with an increased risk